Accueil
Détail de l'éditeur
Documents disponibles chez cet éditeur (436)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
FRANÇAIS : La disponibilité élevée de tous les types de drogues illicites, la production de substances en Europe et la forte teneur en principe actif figurent parmi les préoccupations abordées aujourd'hui par l'Observatoire européen des drogues[...]Rapport
FRANÇAIS : L'Observatoire européen des drogues et des toxicomanies (EMCDDA) a publié le 9 juin 2021 son nouveau rapport sur les drogues, disponible en 24 langues. Celui-ci analyse la situation du marché, des consommations, de leurs conséquences[...]Rapport
FRANÇAIS : Le rebond rapide de l'offre et de la consommation de drogues à la suite des perturbations liées à la COVID-19 est l'un des problèmes mis en évidence dans le Rapport européen sur les drogues 2022. Ce rapport fournit la dernière vue d'[...]Rapport
Using trendspotter methodology, this report explores signs of increasing availability and consumption of cocaine in Europe, in an effort to increase our understanding of recent changes in the cocaine market. The study investigates the consequenc[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2016This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]Rapport
The purpose of this paper is to discuss the different goals of 'drug treatment' within a European context and the key implications for those planning or delivering health and social responses. The heterogeneity of people who use drugs and the di[...]Rapport
OEDT = EMCDDA ; L. VAN AERTS ; J. DE MORAIS ; M. EVANS-BROWN ; R. JORGE ; A. GALLEGOS ; R. CHRISTIE ; T. NÉFAU ; G. PLANCHUELO ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2022The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe. To support this, the report also provides a state-of-the-art review of the chemistry, pharmacology and toxico[...]Rapport
This paper offers a comparison of the drug strategies and plans adopted over the last five years by six intergovernmental organisations engaging 148 countries in four continents. It informs decision-makers, professionals and researchers working [...]Rapport
This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.Rapport
ENGLISH : This report contains the proceedings of a seminar co-organised by EMCDDA and the University of York to consider how modelling techniques could be used to address policy questions and how the results of such modelling could be dissemi[...]Rapport
OEDT = EMCDDA ; S. ELLIOTT ; S. BRANDT | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe), that was conducted by the Scientific Committee of the EMCDDA. Concer[...]Rapport
The risk-assessment reports on the synthetic drugs 2C-I; 2C-T-2 and 2C-T-7 were submitted by the EMCDDA to the European Council and Commission on 4 April 2003. The reports were drawn up at a meeting in Lisbon from 31 March to 1 April under the a[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921), that was conducted by the Scientific Committee of the EMCDDA. Concern[...]Rapport
FRANÇAIS : L'Observatoire européen des drogues et toxicomanies présente les résultats de son étude sur l'évolution des risques concernant la 4-méthylthioamphétamine ou 4-MTA. Cette nouvelle drogue de synthèse est connue des autorités des Etats[...]Rapport
ENGLISH : This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The[...]